WASHINGTON, April 27 (Reuters) - Invibio, a division of
Victrex PLC that makes a key polymer used in spinal and
other medical implants, agreed to settle allegations that it
demanded exclusive contracts to illegally maintain its high
market share, the Federal Trade Commission said on Wednesday.
Read more
No comments:
Post a Comment